Summary
Although growth hormone is known to be the main regulator of insulin-like growth factor-I, insulin has also been shown to play a role in regulating serum insulin-like growth factor I levels in diabetic animals. While this effect is thought to be due to correction of metabolic perturbations, some studies have suggest that insulin may have a direct effect on growth and/or insulin-like growth factor-I levels. We have examined the effects of acute and chronic insulin administration to non-diabetic, pituitary-intact and hypophysectomised rats. Rats were injected intraperitoneally with insulin as an acute bolus (10 U) or a chronic subcutanious infusion (low dose; 2.4 U/day, high dose; 12 U/day) over 5 days. Insulin-like growth factor-I mRNA was quantitated by Northern and slot blots of RNA from various tissues. A small (less than 2-fold) but significant increase (p<0.05) was seen in hepatic insulin-like growth factor-I mRNA abundance in pituitary-intact rats following acute insulin injection and chronic low dose insulin infusion. An increase in insulin-like growth factor-I mRNA levels was also seen in other tissues including diaphragm, lung, kidney and heart. A significant increase (p<0.05) in serum insulin-like growth factor-I levels was also observed 6 h after insulin injection. In contrast, in pituitary-intact rats which received high dose insulin infusion and were hypoglycaemic at the time of death, tissue levels of insulin-like growth factor-I mRNA were reduced compared to saline-treated control groups. Similarly in the hypophysectomised rats neither acute nor chronic insulin administration had any consistent effect on insulin-like growth factor-I mRNA abundance in any of the tissues examined. This data suggests that insulin has no direct effect in regulating insulin-like growth factor-I gene expression. The small effects demonstrable in pituitary-intact rats may result from a synergistic action of insulin with growth hormone or other pituitary factors.
Article PDF
Similar content being viewed by others
References
Chochinov RH, Daughaday WH (1976) Current concepts of somatomedin and other biologically related growth factors. Diabetes 25: 994–1004
Zapf J, Rinderknecht E, Humbel RE, Froesch ER (1978) Nonsuppressable insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism 27: 1803–1828
Schoenle E, Zapf J, Hauri CH, Steiner TH, Froesch ER (1985) Comparison of in vivo effects of insulin-like growth factor I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol 108: 167–174
Murphy LJ, Murphy LC, Friesen HG (1988) Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol 1: 445–450
Francis MJO, Hill DJ (1983) Prolactin-stimulated production of somatomedin by rat liver. Nature 255: 167–168
Kenny FM, Iturzaeta NF, Mintz D, Drash A, Garces LY, Susen A, Askari HA (1968) Iatrogenic hypopituitarism in craniopharyngioma: unexplained catch-up growth in three children. J Pediatr 72: 766–775
Schalch D, Heinrich U, Draznin B, Johnson C, Miller L (1979) Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 104: 1143–1151
Winter RJ, Phillips LS, Green OC, Traisman HS (1980) Somatomedin activity in the Mauriac syndrome. J Pediatr 97: 598–600
Costin G, Kogut MD, Phillips LS, Daughaday WH (1976) Craniopharyngioma: the role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 42: 370–375
Copinschi G, Wegienka LC, Hane S, Forsham PH (1967) Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metabolism 16: 485–491
Maes M, Ketelslegers J-M, Underwood LE (1983) Low plasma somatomedin-c in streptozotocin-induced diabetes mellitus. Correlation with changes in somatogenic and lactogenic liver binding sites. Diabetes 32: 1060–1069
Griffen SC, Russel SM, Katz LS, Nicole CS (1987) Insulin exerts metabolic and growth promoting effects by a direct action on the liver in vivo: clarification of the functional significance of the portal vascular link between the beta cells of the pancreatic islets and the liver. Proc Natl Acad Sci USA 88: 7300–7304
Kogawa M, Takano K, Asakawa K, Hizuka N, Tsushima T, Shizume K (1983) Insulin stimulation of somatomedin A production in monolayer cultures of rat hepatocytes. Acta Endocrinol 108: 1265–1271
Scott CD, Baxter RC (1986) Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology 119: 2346–2352
Miller L, Schalch D, Draznin B (1981) Role of the liver in regulating somatomedin activity: effects of streptozotocin diabetes and starvation on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 108: 1265–71
Daughaday W, Phillips L, Mueller M (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98: 1214–1219
D'Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81: 935–941
Murphy LJ, Bell GI, Duckworth ML, Friesen HG (1987) Identification, characterization and regulation of a rat cDNA which encodes insulin-like growth factor-I. Endocrinology 121: 684–691
Chirgwin J, Pryzbyla A, MacDonald R, Rutter W (1979) Isolation of biologically active ribonucleic acid from sources enriched for ribonuclease. Biochemistry 18: 5294–5299
Aviv H, Leder P (1972) Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA 69: 1408–1412
Gonzalez IL, Gorski JL, Campen TJ, Dorney DJ, Erickson JM Sylvester JE, Schmickel RD (1985) Variation among human 28S ribosomal RNA genes. Proc Natl Acad Sci USA 82: 7666–7670
Murphy LJ, Friesen HG (1988) Differential Effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor-I gene expression in the ovariectomized hypophysectomised rat. Endocrinology 122: 325–332
King GL, Kahn CR, Rechler MM Nissley SP (1980) Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptor. J Clin Invest 66: 130–140
Koontz JW, Iwahashi M (1981) Insulin as a potent, specific growth factor in a rat hepatoma cell line. Science 211: 947–949
Baxter RC, Bryson JM, Turtle JR (1980) Somatic receptors of rat liver: regulation by insulin. Endocrinology 107: 1176–1181
Phillips LS, Young HS (1976) Nutrition and somatomedin II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats. Diabetes 25: 516–527
Takano K, Hizuka N, Shizume K, Hasumi Y, Kogawa M, Tsushima T (1980) Effect of insulin and nutrition on serum levels of somatomedin A in the rat. Endocrinology 107: 1614–1619
Taylor AM, Sharma AK, Avasthy N, Duguid IGM, Blanchard DS, Thomas PK, Dandona P (1987) Inhibition of somatomedin-like activity by serum from streptozotocin-diabetic rats: Prevention by insulin treatment and correlation with skeletal growth. Endocrinology 121: 1360–1365
Salter J, Best CH (1953) Insulin as a growth hormone. Br Med J 2: 353–356
Grant DB, Hambley J, Becker D, Pimstone BL (1973) Reduced sulfation factor in undernourished children. Arch Dis Child 48: 569–600
Takahashi K, Daughaday WH, Kipnis DM (1971) Regulation of immunoreactive growth hormone secretion in male rats. Endocrinology 88: 909–917
Busby WH, Snyder DK, Clemmons DR (1988) Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. J Clin Endocrinol Metab 67: 1225–1230
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salamon, E.A., Luo, J. & Murphy, L.J. The effect of acute and chronic insulin administration on insulin-like growth factor-I expression in the pituitary-intact and hypophysectomised rat. Diabetologia 32, 348–353 (1989). https://doi.org/10.1007/BF00277257
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00277257